SCM
BOLD

Stevens Capital Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

Stevens Capital Management’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-35,046
Closed -$2.1M – 548
2019
Q4 		$2.1M Buy
+35,046
New +$1.32M 0.2% 134

Stevens Capital Management's BOLD Position: Q1 2020 in Review

Stevens Capital Management sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 35,046 shares — an estimated $2.1M sold.

Stevens Capital Management first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $2.1M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Stevens Capital Management reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Stevens Capital Management sold 35,046 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $2.1M.
  • Stevens Capital Management first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
  • Stevens Capital Management's Audentes Therapeutics, Inc position peaked at $2.1M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Stevens Capital Management's 13F filing for Q1 2020, filed 21 Apr 2020.